Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.

Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.

BACKGROUND: Although epidemiological, clinical, and experimental evidence indicates that the inducible isoform of cyclo-oxygenase (COX-2) may be involved in the pathogenesis of several neurodegenerative disorders, the mechanisms whereby COX-2 contributes to Alzheimer's disease are largely unkno...

Bibliografiset tiedot
Päätekijät:	Combrinck, M, Williams, J, Berardinis, D, Warden, D, Puopolo, M, Smith, A, Minghetti, L
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2006

Samankaltaisia teoksia

Peripheral reductive capacity is associated with cognitive performance and survival in Alzheimer's disease
Tekijä: Minghetti, L, et al.
Julkaistu: (2006)

Peripheral reductive capacity is associated with cognitive performance and survival in Alzheimer's disease.
Tekijä: Minghetti, L, et al.
Julkaistu: (2006)

Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease.
Tekijä: Belbin, O, et al.
Julkaistu: (2007)

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
Tekijä: Belbin, O, et al.
Julkaistu: (2009)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
Tekijä: Oulhaj, A, et al.
Julkaistu: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Tekijä: Oulhaj, A, et al.
Julkaistu: (2010)

Decreased CSF acetylcholinesterase activity in Alzheimer's disease.
Tekijä: Appleyard, M, et al.
Julkaistu: (1983)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
Tekijä: Holmes, C, et al.
Julkaistu: (2005)

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.
Tekijä: Lai, M, et al.
Julkaistu: (2002)

The effects of cell cycle progression and Alzheimer-type pathology on cognitive decline
Tekijä: Smith, M, et al.
Julkaistu: (2000)

Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease
Tekijä: Allen, G, et al.
Julkaistu: (2016)

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
Tekijä: Delvenne, A, et al.
Julkaistu: (2024)

Constructional apraxia in Alzheimer's disease: association with occipital lobe pathology and accelerated cognitive decline.
Tekijä: Smith, M, et al.
Julkaistu: (2001)

The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
Tekijä: Westwood, S, et al.
Julkaistu: (2017)

The soluble transcobalamin receptor (sCD320) in relation to Alzheimer's disease and cognitive scores.
Tekijä: Abuyaman, O, et al.
Julkaistu: (2017)

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
Tekijä: Martins, C, et al.
Julkaistu: (2005)

Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
Tekijä: Nho, K, et al.
Julkaistu: (2018)

Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease.
Tekijä: De Jager, C, et al.
Julkaistu: (2003)

Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease.
Tekijä: Chance, SA, et al.
Julkaistu: (2011)

Low free testosterone is an independent risk factor for Alzheimer's disease
Tekijä: Hogervorst, E, et al.
Julkaistu: (2004)

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
Tekijä: Ballard, C, et al.
Julkaistu: (2005)

Response to treatment with TNFα inhibitors in rheumatoid arthritis is associated with high levels of GM-CSF and GM-CSF(+) T lymphocytes
Tekijä: Bystrom, J, et al.
Julkaistu: (2017)

Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
Tekijä: Ballard, C, et al.
Julkaistu: (1996)

Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men.
Tekijä: Hogervorst, E, et al.
Julkaistu: (2002)

Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method.
Tekijä: Hogervorst, E, et al.
Julkaistu: (2003)

Effect of inhaled prostaglandin E2 on allergen-induced asthma.
Tekijä: Pavord, I, et al.
Julkaistu: (1993)

Serum total testosterone is lower in men with Alzheimer's disease.
Tekijä: Hogervorst, E, et al.
Julkaistu: (2001)

Telomerase reverse transcriptase preserves neuron survival and cognition in Alzheimer’s disease models
Tekijä: Shim, Hong Seok, et al.
Julkaistu: (2023)

Low free testosterone is an independent risk factor for Alzheimer's disease.
Tekijä: Hogervorst, E, et al.
Julkaistu: (2004)

Bronchoprotective role for endogenous prostaglandin E2.
Tekijä: Pavord, I, et al.
Julkaistu: (1995)

A SNP in the ACT gene associated with astrocytosis and rapid cognitive decline in AD.
Tekijä: Belbin, O, et al.
Julkaistu: (2008)

Loss of serotonin 5-HT2A receptors in, the temporal cortex correlates with cognitive decline in Alzheimer's disease
Tekijä: Lai, K, et al.
Julkaistu: (2004)

Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.
Tekijä: Williams, S, et al.
Julkaistu: (2009)

Normal cognitive decline or dementia?
Tekijä: Ebmeier, K
Julkaistu: (2010)

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.
Tekijä: Green, R, et al.
Julkaistu: (2009)

Resolving postoperative neuroinflammation and cognitive decline.
Tekijä: Terrando, N, et al.
Julkaistu: (2011)

Analysing the effect of CSF inflammatory proteins on stroke severity in people with varying severities of Alzheimer's disease
Tekijä: Chan, Shawn Kiat Zhong
Julkaistu: (2023)

Association of the androgen receptor CAG repeat polymorphism with Alzheimer's disease in men.
Tekijä: Lehmann, D, et al.
Julkaistu: (2003)

Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.
Tekijä: Robson, K, et al.
Julkaistu: (2004)

Prostaglandin research /
Tekijä: Crabbe, Pierre
Julkaistu: (1977)